Validity and Reproducibility of OSND (Objective Score of Nutrition on Dialysis) as a Nutritional Marker in End-stage Renal Disease
Launched by ASSAF-HAROFEH MEDICAL CENTER · Oct 4, 2010
Trial Information
Current as of July 23, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Male or female, age \> 18 years, in chronic hemodialysis treatment at least 3 months
- • 2. Stable and adequate hemodialysis treatment three months prior to participation in study as defined by Kt/V \> 1.2 and/or hemodialysis performed 4 hours 3 times weekly
- • 3. Patients with normal hydration status (edema-free), with no neuroid-muscular diseases
- • 4. Informed consent obtained before any trial-related activities
- Exclusion Criteria:
- • 1. Patients with edema, pleural effusion or ascites at their initial assessment
- • 2. Patients with active malignant disease or liver cirrhosis
- • 3. Patients with neuroid-muscular diseases
- • 4. Patients on chronic treatment with steroids on doses \> 10 mg/day Prednisone (or equivalent)
- • 5. Patients treated with immunosuppressive agents
- • 6. Patients suffering from
- • Acute vasculitis
- • Severe systemic infections
- • Heart failure (NYHA class III-IV)
About Assaf Harofeh Medical Center
Assaf-Harofeh Medical Center is a prominent healthcare institution located in Israel, renowned for its commitment to advancing medical research and improving patient care. As a key sponsor of clinical trials, the center focuses on a diverse range of therapeutic areas, leveraging its state-of-the-art facilities and interdisciplinary expertise to facilitate innovative studies. With a dedicated team of experienced researchers and clinicians, Assaf-Harofeh Medical Center is dedicated to fostering scientific breakthroughs that enhance treatment outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zerifin, , Israel
Patients applied
Trial Officials
Ilia Beberashvili, MD
Principal Investigator
Nephrology division Assaf Harofeh Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials